Validity of postoperative adjuvant chemotherapy for non-small cell lung cancer

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Objective. To assess the efficacy of postoperative adjuvant chemotherapy for completely resected pathologic (p-) stage IB-IIIA non-small cell lung cancer (NSCLC) and to examine the validity in clinical practice. Methods. All the reported prospective randomized studies on postoperative adjuvant chemotherapy in more than 100 patients with resected NSCLC were reviewed. Results. Most chemotherapy regimens such as cisplatin-based intravenous chemotherapy regimens failed to improve the postoperative survival of patients with completely resected NSCLC. However, some prospective studies suggested that two oral drugs, UFT and ubenimex, could be effective as postoperative adjuvant therapy for resected NSCLC, whereas these two drugs showed minimal anti-tumor effect against advanced NSCLC. These results show that drugs that can be administrated for a long time after surgery, not drugs with potent anti-tumor activity, may be used postoperatively. Conclusion. It is clinically valid to perform postoperative adjuvant therapy using drugs that can be given with good compliance, such as UFT and ubenimex, whereas the efficacy has not been established.

References Powered by Scopus

Revisions in the international system for staging lung cancer

4584Citations
N/AReaders
Get full text

A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer

1263Citations
N/AReaders
Get full text

A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage iiia non-small-cell lung cancer

1122Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer

7Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tanaka, F., & Wada, H. (2002). Validity of postoperative adjuvant chemotherapy for non-small cell lung cancer. Japanese Journal of Lung Cancer, 42(7), 765–770. https://doi.org/10.2482/haigan.42.765

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

75%

Researcher 1

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

50%

Nursing and Health Professions 2

50%

Save time finding and organizing research with Mendeley

Sign up for free